M. R. Campbell

Most-cited papers

1. Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities

   J. Syrjanen, M. R. Campbell, A. Algeciras-Schimnich, P. Vemuri +7 more

   2021Alzheimer's & Dementia239 citations Open access

   Semantic Scholar

   Save

2. Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology

   D. Shir, J. Graff-Radford, Ekaterina I. Hofrenning, T. Lesnick +10 more

   2022Alzheimer's & Dementia127 citations Open access

   Semantic Scholar

   Save

3. Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes

   Jordan D. Marks, J. Syrjanen, J. Graff-Radford, R. Petersen +8 more

   2021Alzheimer's Research & Therapy75 citations Open access

   Semantic Scholar

   Save

4. Plasma Neurofilament Light Chain (NfL) Reference Interval Determination in an Age-stratified Cognitively Unimpaired Cohort.

   J. Bornhorst, D. Figdore, M. R. Campbell, Vanessa K. Pazdernik +3 more

   2022Clinica chimica acta; international journal of clinical chemistry48 citations

   Semantic Scholar

   Save

5. Amyloid PET detects the deposition of brain Aβ earlier than CSF fluid biomarkers

   V. Lowe, C. Mester, E. Lundt, Jeyeon Lee +20 more

   2024Alzheimer's & Dementia21 citations Open access

   Semantic Scholar

   Save

6. Role of immune mediators in predicting hospitalization of SARS-CoV-2 positive patients

   S. Ashrafzadeh-Kian, M. R. Campbell, J. Jara-Aguirre, J. Walsh +5 more

   2021Cytokine10 citations Open access

   Semantic Scholar

   Save

7. Alzheimer’s disease CSF biomarker assays: Impact of methodology changes in clinical practice

   M. R. Campbell, Susan Ashrafzadeh Kian, R. Petersen, J. Bornhorst +1 more

   2021Alzheimer's & Dementia3 citations

   Semantic Scholar

   Save

8. Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays in the United States

   M. R. Campbell, M. Binnicker

   2022Clinics in Laboratory Medicine2 citations Open access

   Semantic Scholar

   Save

9. Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes

   Jordan D. Marks, J. Syrjanen, J. Graff-Radford, R. Petersen +8 more

   2021Alzheimer's Research & Therapy2 citations Open access

   Semantic Scholar

   Save

10. Body Fluid Processing Workspace Quality Improvement Initiative in a High-Volume Reference Laboratory

    M. R. Campbell, Karrie K Milam, K. R. Fisher

    2018American Journal of Clinical Pathology2 citations Open access

    Semantic Scholar

    Save

11. Corrigendum to "Plasma neurofilament light chain (NfL) reference interval determination in an age-stratified cognitively unimpaired cohort" [Clin. Chim. Acta 535 (2022) 153-156].

    J. Bornhorst, D. Figdore, M. R. Campbell, Vanessa K. Pazdernik +3 more

    2023Clinica chimica acta; international journal of clinical chemistry1 citations Open access

    Semantic Scholar

    Save

12. Analytical Validation of the Quanterix Neurofilament Light Chain (NfL) Advantage Assay in Plasma

    D. Figdore, M. R. Campbell, J. Syrjanen, M. Mielke +3 more

    2022Alzheimer's & Dementia1 citations

    Semantic Scholar

    Save

13. A Process Improvement Project to Increase Diabetic Retinopathy Screening Rates as Evidenced by Formal Documentation

    M. R. Campbell

    20171 citations

    Semantic Scholar

    Save

14. Amyloid PET Detects the Deposition of Brain Aβ Earlier than CSF Fluid Biomarkers

    V. Lowe, C. Mester, E. Lundt, Jeyeon Lee +17 more

    2024Alzheimer's & Dementia0 citations

    Semantic Scholar

    Save

15. Factors associated with levels of plasma markers of amyloid pathology and neurodegeneration in a population‐based sample

    J. Syrjanen, M. R. Campbell, A. Algeciras-Schimnich, P. Vemuri +6 more

    2021Alzheimer's & Dementia0 citations

    Semantic Scholar

    Save